HemaCare Reverses Loss; Reports $55,000 Profit
HemaCare, a Sherman Oaks-based provider of blood products and services, reported a $55,000 profit for the first quarter, in contrast to a year-earlier loss of $118,168.
HemaCare said the profit, which equaled 2 cents a share, came on a 42% increase in revenue in the quarter ended March 31, to $1.07 million from $749,935.
The company said the improved results largely reflected a 62% jump in revenue, to $642,000 in the latest quarter, from HemaCare’s therapeutic hemapheresis treatments. The treatment, administered at a patient’s bedside, removes harmful substances from the blood. It is given to patients with such diseases as leukemia and multiple sclerosis.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
